Fmoc-L-MeAsp(tBu)-OH

Fmoc-L-MeAsp(tBu)-OH is an Fmoc-protected, side-chain modified amino acid derivative based on L-methionine-? (MeAsp) with a tert-butyl-protected side-chain carboxylate, forming a protected amino acid suitable for peptide chemistry. The molecule contains a free amino group masked by the Fmoc carbamate on the alpha-amine, a carboxylic acid at the alpha position, and a tert-butyl ester on the side-chain carboxyl functionality, with stereochemistry indicated as L in the product name. In synthesis, the orthogonal protection pattern supports stepwise assembly of peptides or peptide fragments on solid or solution-phase platforms while providing a controlled handle for side-chain deprotection and incorporation of the modified Asp residue into structure-activity or chemical biology studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-L-MeAsp(tBu)-OH(CAS 152548-66-8)

CAT No: CP25391

CAS No:152548-66-8

Synonyms/Alias:Fmoc-N-Me-Asp(OtBu)-OH;152548-66-8;Fmoc-MeAsp(OtBu)-OH;fmoc-n-methyl-l-aspartic acid 4-tert-butyl ester;MFCD00237027;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-aspartic acid beta-t-butyl ester;Fmoc-N-methyl-L-aspartic acid b-tert-butyl ester;Fmoc-L-MeAsp(tBu)-OH;(2S)-4-(tert-butoxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-4-oxobutanoic acid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid;N-Fmoc-N-methyl-L-aspartic Acid 4-tert-Butyl Ester;Fmoc-L-MeAsp(OtBu)-OH;Fmoc-N-Me-L-Asp(OtBu)-OH;Fmoc-Nalpha-methyl-L-aspartic acid beta-t-butyl ester;SCHEMBL1759730;CYWWLVIEAOUXGW-FQEVSTJZSA-N;N-alpha-Fmoc-N-alpha-methyl-L-aspartic acid beta-t-butyl ester;Fmoc-N-Me-Asp(OtBu)-OH, 97%;AKOS015895306;CS-W014456;FF48597;HY-W013740;AC-31987;DS-13719;F12339;Fmoc-Nalpha-methyl-L-aspartic acid beta-t-butylester;(S)-2-[(9H-fluoren-9-ylmethoxycarbonyl)-methyl-amino]-succinic acid 4-tert-butyl ester;(2S)-2-(9H-fluoren-9-ylmethoxycarbonyl-methylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-tert-butoxy-4-oxobutanoic acid;802-787-3;

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-aspartic acid beta-t-butyl ester

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C24H27NO6
M.W/Mr.
425.5
Sequence
Three Letter Code:Fmoc-N(Me)Asp(OtBu)(OtBu)-OH

Fmoc-L-MeAsp(tBu)-OH is an Fmoc-protected, stereodefined methionine-derived aspartic acid analog in which the side-chain carboxyl group is masked as a tert-butyl ester and the alpha-amino functionality is protected as an Fmoc carbamate. The molecule contains a single stereogenic center at the L-alpha position, a protected amine suitable for base-mediated peptide assembly, and an additional carboxyl functionality that can be revealed after tert-butyl deprotection. The Fmoc group provides orthogonal protection relative to acid-labile tert-butyl esters, enabling controlled exposure of the amino and side-chain carboxyl groups during stepwise synthesis. The resulting protected amino acid derivative functions as a chiral building block for peptide coupling and as a downstream intermediate for aspartate-containing motifs and functionalized side-chain carboxyl chemistry.

1. Peptide Synthesis

Fmoc-L-MeAsp(tBu)-OH is used in peptide synthesis workflows to construct aspartate-containing sequences with orthogonally protected functional groups. The Fmoc carbamate on the alpha-amine supports standard peptide coupling chemistry after base-triggered Fmoc removal, while the side-chain tert-butyl ester protects the aspartate carboxyl from premature acylation or side reactions. The defined L-configuration at the alpha-carbon supports stereochemically consistent incorporation into growing peptide chains, including sequences where aspartate side-chain participation is required for binding or catalysis. The protected amino acid derivative can be employed to prepare peptide building blocks for solid-phase or solution-phase assembly and to generate aspartate motifs after sequential deprotection.

2. Protected Amino Acid Chemistry

Fmoc-L-MeAsp(tBu)-OH serves as a protected amino acid synthesis intermediate for preparing carboxyl-functionalized derivatives with controlled protection-state management. The combination of an acid-labile tert-butyl ester and an Fmoc-protected amine enables orthogonal deprotection strategies that expose either the side-chain carboxyl or the free amine at targeted stages of a synthetic sequence. The presence of both protected and latent functional groups supports downstream transformations such as side-chain activation for amide formation, ester exchange, or conversion into protected aspartate derivatives for further elaboration. The chiral amino acid intermediate nature of Fmoc-L-MeAsp(tBu)-OH also makes it suitable for manufacturing route design where protection group compatibility and predictable deprotection behavior are required.

3. Peptidomimetics And SAR Studies

Fmoc-L-MeAsp(tBu)-OH can be applied in peptidomimetic construction and structure-activity relationship studies where aspartate side-chain geometry and carboxyl availability influence molecular recognition. The protected side-chain carboxyl enables incorporation into analog libraries without uncontrolled cross-linking during synthesis, while later deprotection can provide a handle for salt formation, hydrogen-bonding pattern tuning, or conjugation-ready functionality. The Fmoc-protected alpha-amine supports coupling into non-natural peptide scaffolds, including constrained or modified backbones that retain stereochemical fidelity at the L-alpha center. The resulting aspartate-bearing analogs can be used to generate structure-defined series for SAR investigations and for mapping how side-chain carboxyl presentation affects binding interactions.

4. Chemical Biology Conjugation

Fmoc-L-MeAsp(tBu)-OH supports chemical biology research and bioconjugation chemistry through controlled introduction of an aspartate side-chain carboxyl group into peptide-based probes. The tert-butyl-protected carboxyl can be preserved during assembly of labeled or targeting peptides, then deprotected to provide a reactive acidic functional group for subsequent coupling strategies such as amide bond formation or linker attachment. The Fmoc group enables sequential build-up of conjugate-ready constructs while minimizing undesired side reactions involving the amino functionality. The stereodefined, side-chain-functionalized peptide building block can be incorporated into affinity reagents, enzyme substrate analogs, or detection probes where carboxyl-mediated interactions and linker orientation are relevant.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-MeAsp(tBu)-OH is suitable for pharmaceutical manufacturing-oriented fine chemical synthesis where protected amino acid building blocks are required for reproducible peptide intermediate preparation. The orthogonal protection pattern, with Fmoc on the alpha-amine and tert-butyl on the side-chain carboxyl, supports scalable synthesis of aspartate-containing intermediates that can be carried through controlled deprotection and coupling steps. The defined stereochemistry helps maintain consistency across manufacturing batches by ensuring the intended L-configuration at the incorporation site. The protected amino acid derivative can be utilized to prepare peptide fragments and aspartate-rich intermediates that feed into downstream drug substance or drug product-related peptide construction processes.

6. Analytical Research Standards

Fmoc-L-MeAsp(tBu)-OH can be employed in analytical research as a stereochemically defined reference material for method development and characterization of aspartate-containing peptide products. The presence of both Fmoc and tert-butyl-protected functionalities provides characteristic mass and fragmentation behavior that can support LC-MS or MS/MS identification of protected intermediates and deprotected aspartate species. The compound's defined L-configuration and protected side-chain carboxyl state enable unambiguous tracking of synthesis steps, including monitoring of Fmoc removal and tert-butyl ester deprotection endpoints. The amino acid-based intermediate can also serve as a calibration or verification standard when assessing peptide coupling outcomes and protecting-group integrity in peptide chemistry workflows.

Size
1 g;5 g;
InChI
InChI=1S/C24H27NO6/c1-24(2,3)31-21(26)13-20(22(27)28)25(4)23(29)30-14-19-17-11-7-5-9-15(17)16-10-6-8-12-18(16)19/h5-12,19-20H,13-14H2,1-4H3,(H,27,28)/t20-/m0/s1
InChI Key
CYWWLVIEAOUXGW-FQEVSTJZSA-N
Canonical SMILES
CC(C)(C)OC(=O)CC(C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Synthesis ServicescGMP Peptide ServicePeptide Analysis ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers